Diabetes Diagnostics 2015-2022: Global Strategic Business Report 2016 - Medtronic Dominates the Global CGM Devices Market
Dublin, Dec. 16, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Diabetes Diagnostics - Global Strategic Business Report" report to their offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for Diabetes Diagnostics in US$ Thousand by the following Product Segments:
- Continuous Glucose Monitoring (CGM) Systems
- HbA1c Testing Devices
- Blood Glucose Monitoring Devices
The report profiles 58 companies including many key and niche players such as
- Abbott Diabetes Care, Inc. (US)
- Acon Laboratories, Inc. (US)
- AgaMatrix, Inc. (US)
- Alere Inc. (US)
- Animas Corporation (US)
- Apex Biotechnology Corporation (Taiwan)
- ARKRAY, Inc. (Japan)
- Ascensia Diabetes Care Holdings AG (Switzerland)
- A.Menarini Diagnostics Ltd. (UK)
- B. Braun Melsungen AG (Germany)
- Becton, Dickinson and Company (US)
- Bayer Healthcare Diabetes Care (US)
- Beckman Coulter, Inc. (US)
- Bio-Rad Laboratories (US)
- BIONIME Corporation (Taiwan)
- Diazyme Laboratories Inc. (US)
- Dexcom, Inc. (US)
- EKF Diagnostics Holdings Plc (UK)
- HemoCue® AB (Sweden)
- Infopia Co., Ltd. (South Korea)
- LifeScan, Inc. (US)
- Medtronic MiniMed, Inc. (US)
- Nova Biomedical Corporation (US)
- PTS Diagnostics (US)
- Roche Diagnostics (Switzerland)
- Sanofi S.A. (France)
- Sanwa Kagaku Kenkyusho Co, Ltd. (Japan)
- Siemens Healthineers (Germany)
- Taidoc Technology Corporation (Taiwan)
- Tandem Diabetes Care, Inc. (US)
- Terumo Corporation (Japan)
- Tosoh Bioscience, Inc. (US)
- Trinity Biotech plc (Ireland)
- Trividia Health, Inc. (US)
- Ypsomed AG (Switzerland)
Key Topics Covered:
1. Industry Overview
2. Competition
3. Market Trends, Issues & Drivers
4. Diabetes Diagnostics Innovations & Advancements
5. Product Overview
6. Product Launches
7. Recent Industry Activity
8. Focus On Select Global Players
9. Global Market Perspective
Total Companies Profiled: 58 (including Divisions/Subsidiaries 75)
- The United States (35)
- Canada (1)
- Japan (4)
- Europe (23)
- - France (2)
- - Germany (4)
- - The United Kingdom (8)
- - Italy (1)
- - Rest of Europe (8)
- Asia-Pacific (Excluding Japan) (10)
- Middle-East (2)
For more information about this report visit http://www.researchandmarkets.com/research/w859zk/diabetes
CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Related Topics: Diagnostics, Endocrinology
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.